EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

9 Months Ended

Dec. 31, 2012

EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings Per Share

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

	For the quarter ended December 31						For the nine months ended December 31
	2012			2011			2012			2011
Basic earnings per share:
Net earnings from continuing operations	$	14,449		$	1,837		$	44,020		$	22,775
Net earnings from discontinued operations	—			814			—			2,868
Net earnings	$	14,449		$	2,651		$	44,020		$	25,643
Net loss attributable to noncontrolling interest	(76		)	(5,279		)	(349		)	(5,554		)
Net earnings attributable to Acxiom	$	14,525		$	7,930		$	44,369		$	31,197
Basic weighted-average shares outstanding	74,103			78,189			75,195			80,039
Basic earnings per share:
Continuing operations	$	0.19		$	0.02		$	0.59		$	0.28
Discontinued operations	—			$	0.01		—			$	0.04
Net earnings	$	0.19		$	0.03		$	0.59		$	0.32
Net loss attributable to noncontrolling interest	—			$	(0.07	)	—			$	(0.07	)
Net earnings attributable to Acxiom	$	0.20		$	0.10		$	0.59		$	0.39
Diluted earnings per share:
Basic weighted-average shares outstanding	74,103			78,189			75,195			80,039
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	1,775			831			1,792			838
Diluted weighted-average shares outstanding	75,878			79,020			76,987			80,877
Diluted earnings per share:
Continuing operations	$	0.19		$	0.02		$	0.57		$	0.28
Discontinued operations	—			$	0.01		—			$	0.04
Net earnings	$	0.19		$	0.03		$	0.57		$	0.32
Net loss attributable to noncontrolling interest	—			$	(0.07	)	—			$	(0.07	)
Net earnings attributable to Acxiom	$	0.19		$	0.10		$	0.58		$	0.39

Some earnings per share amounts may not add due to rounding.

As of December 31, 2012, the Company had options and warrants outstanding providing for the purchase of approximately 9.7 million shares of common stock together with restricted stock units relating to 1.2 million shares of stock. Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

	For the quarter ended December 31				For the nine months ended December 31
	2012		2011		2012		2011
Number of shares outstanding under options, warrants and restricted stock units	4,752		9,515		7,872		9,438
Range of exercise prices for options and warrants	$	17.76-$62.06	$	12.25-$62.06	$	13.10-$62.06	$	13.14-$62.06

Stockholders’ Equity

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, on May 24, 2012, and again on February 5, 2013.  Under the modified common stock repurchase program, the Company may purchase up to $200.0 million of its common stock through the period ending February 5, 2014.  During the nine months ended December 31, 2012, the Company repurchased 4.1 million shares of its common stock for $62.7 million.  Cash paid for acquisition of treasury stock in the condensed consolidated statement of cash flows may differ from the aggregate purchase price due to trades made during one fiscal period that settle in a different fiscal period.  Through December 31, 2012, the Company had repurchased 9.9 million shares of its stock for $130.9 million, leaving remaining capacity of $69.1 million under the stock repurchase program.